Balai Pembinaan dan Pelatihan Olahraga Pelajar Provinsi Jawa Tengah
Semarang, Central Java, 50231, Indonesia
NCT Number: NCT07476573
The aim of this research is to analyze the effect of a Lactiplantibacillus plantarum Dad-13 supplementation on the gut microbiota profile and performance of adolescent athletes.
Trial opening soon.
Get Notified12 year–18 year
All sexes
Interventional
Not applicable
Semarang, Central Java, 50231, Indonesia
An athlete's physical performance can be influenced by the balance of gut microbiota in the digestive tract. Research shows that as many as 96% of ultramarathon participants (161 km) experience several digestive symptoms such as belching, nausea, vomiting and stress with a failure to reach 35.6% in completing the race. The diversity of an athlete's gut microbiota is higher than that of a normal person. This study is a true experimental study with a double-blind, pre- and posttest randomized controlled trial with a total of 30 athletes as respondents. There are two treatments: the first group will be given 1 gram of capsule preparation containing the probiotic Lactiplantibacillus plantarum Dad-13 given twice/day and the control group given a placebo capsule twice/day. The probiotic intervention was given at breakfast and dinner for 8 weeks. Measurement of the microbiota profile comes from fecal samples to further measure digestive tract health, SCFA levels, and calprotectin concentrations. Analysis of alpha diversity and beta diversity using Microbiome Analyst software. Physical performance was measured using VO2max using a direct laboratory method, namely the COSMED K5 instrument, before and after the intervention in kg/mL. Food intake was measured using a 24-hour food recall method and physical activity using an activity recall method.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lactiplantibacillus plantarum Dad-13 is an indigenous probiotic strain isolated from the curd produced by spontaneous fermentation of buffalo milk in bamboo containers and originates from Minangkabau, West Sumatra, Indonesia.
Other names: Dad-13
Time frame: From pre treatment and the end of treatment at 8 weeks
Gut microbiota profiles were measured from fecal samples, then isolated using 16S rDNA sequencing. Fecal samples were collected in the morning.
Results: alfa and beta diversity
Time frame: pre treatment and end of treatment at 8 weeks
The total level or amount of short chain fatty acid metabolites produced from the fermentation process in the intestine obtained from feces.
Results: Total amount of SCFA, acetic acid, propionic acid, butyric acid
Time frame: pre treatment and the end of treatment at 8 weeks
The physical performance measurement used was VO2max. The VO2max measurement method used a direct laboratory method with COSMED K5 before and after the intervention, with units of kg/mL.
Time frame: pre treatment and the end of treatment at 8 weeks
Protein in white blood cells that acts as an inflammation marker with measurement using ELISA. Fecall samples was used.
Contact information is provided by the study sponsor or research team.
Lilly Arsanti Lestari, Dr.
CONTACT
Natalia Desy Putriningtyas, Dietisien., M.Gizi
CONTACT
Gadjah Mada University
Other
Acronym: Dad-13
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07171047
Athlete, Healthy
Thalgau, State of Salzburg, Austria
View Trial DetailsNCT05067426
Athlete, Healthy
Salzburg, Austria
View Trial DetailsNCT07716319
Athlete, Exercise Training
Madison, Wisconsin, United States
View Trial DetailsNCT07546513
Athlete, Elite Athlete
Wuhan, Hubei, China
View Trial Details